Therefore, the combination of miR-34a and PD-L1 siRNA (siPD-L1) effectively downregulates PD-L1 and CD44 expression in tumor cells and increases tumor cells’ sensitivity to apoptotic signals. This evidence concerns the gene CD44 and neoplasm.